Our research illustrates that RIPK4 can reduce the expression of N-cadherin, Zeb-1, and vimentin in HCC, and our research also found that RIPK4 can regulate HCC EMT and reduce the invasion and metastasis of HCC cells. This evidence concerns the gene RIPK4 and hepatocellular carcinoma.